Indication

Tyrosine Kinase Inhibitors

1 clinical trial

1 product

Clinical trial

Discontinuation of TyrosIne Kinase Inhibitors (ITK) in Chronic Myeloid Leukemia (LMC) and Impact on the Immune System: a Randomized Comparative Study of Two Therapeutic Strategies

Status: Recruiting, Estimated PCD: 2028-12-01

Product